Journal of Medical Physics
 Home | Search | Ahead of print | Current Issue | Archives | Instructions | Subscription | Login  The official journal of AMPI, IOMP and AFOMP      
 Users online: 260  Home  EMail this page Print this page Decrease font size Default font size Increase font size 
ORIGINAL ARTICLE
Year : 2020  |  Volume : 45  |  Issue : 4  |  Page : 226-233

Is synchronous bilateral breast irradiation using flattening filter-free beam-based volumetric-modulated arc therapy beneficial? A dosimetric study


1 Department of Physics, School of Advanced Science, Vellore Institute of Technology, Vellore, Tamil Nadu; Department of Radiation Oncology, Yashoda Hospitals, Hyderabad, Telangana, India
2 Department of Physics, School of Advanced Science, Vellore Institute of Technology, Vellore, Tamil Nadu, India

Correspondence Address:
Dr. K Veluraja
Department of Physics, School of Advanced Science, Vellore Institute of Technology, Vellore - 632 014, Tamil Nadu
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jmp.JMP_32_20

Rights and Permissions

Objective: The aim of this study is to validate the clinical use of flattening filter-free (FFF) beam-based volumetric-modulated arc therapy (VMAT) in synchronous bilateral breast carcinoma (SBBC) patient treatments and to compare with flattening filtered (FF) beam-based VMAT. Materials and Methods: Computed tomography images of 15 SBBC patients were taken for this study. A dose of 50 Gy in 25 fractions was prescribed to planning target volume (PTV). VMAT plans were generated using both FFF and FF 6 MV X-ray beams in Eclipse treatment planning system. PTV and organs at risk (OARs) doses were analyzed quantitatively using dose–volume histograms (DVHs) to meet plan objectives. Pretreatment point and planar dosimetry were performed. Results: The findings were reported as mean ± 1 standard deviation. PTV volume receiving 95% of the prescribed dose was 95.71% ± 0.65% for FF-VMAT and 95.45% ± 1.33% for FFF-VMAT (P = 0.743). Conformity index was 1.12 ± 0.31 (FF-VMAT) and 1.12 ± 0.02 (FFF-VMAT). Right lung mean dose was 10.95 ± 1.33 Gy (FF-VMAT) and 10.60 ± 98.5 (FFF-VMAT). Left lung mean dose was 9.73 ± 1.56 (FF-VMAT) and 9.61 ± 1.53 Gy (FFF-VMAT). Tumor control probability (TCP) was 99.68% ± 0.02% (FF-VMAT) and 99.67% ± 0.01% (FFF-VMAT) (P = 0.390). Uncomplicated TCP was 98.72% ± 0.02% (FF-VMAT) and 98.72% ± 0.01% (FFF-VMAT) (P = 0.508). Conclusion: The planning objective parameters achieved using FFF-based VMAT showed that FFF can also be used clinically to treat bilateral breast carcinomas and the low-dose lung volumes were still lesser with FFF-VMAT plans than FF-VMAT.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed358    
    Printed8    
    Emailed0    
    PDF Downloaded109    
    Comments [Add]    

Recommend this journal